Financial and Investment Analysts H-1B salary at Novo Nordisk Pharmaceutical Industries, LP: $88,528 average ($88,528-$88,528 range). 100% approval rate.
Novo Nordisk Pharmaceutical Industries, LP has filed 1 H-1B petition for the Financial and Investment Analysts role, offering an average compensation of $89k. The average offered salary of $89k is 1% above the prevailing wage for this occupation. Most positions are located in North Carolina (100%). The certification rate is 100%. 100% of these filings are for new employment.
| Total Filings | 1 |
| Approval Rate | 100% |
| Average Salary | $88,528 |
| Median Salary | $88,528 |
| 25th Percentile | $88,528 |
| 75th Percentile | $88,528 |
| Minimum Salary | $88,528 |
| Maximum Salary | $88,528 |
100% of filings offer salaries above the prevailing wage, with an average premium of 0.9%. The average prevailing wage is $88k (based on 1 filings with prevailing wage data).
Average processing time is 7 days (median: 7 days). Fastest: 7 days, slowest: 7 days. Based on 1 filings.
100% of filings are for new positions, while 0% are for continued employment (1 filings with data).
Average contract duration: 36 months (median: 36 months), based on 1 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 1 |
| State | Filings |
|---|---|
| North Carolina | 1 |
Novo Nordisk Pharmaceutical Industries, LP has 1 H-1B filings for Financial and Investment Analysts positions in our database of DOL public records.
The average H-1B salary for Financial and Investment Analysts at Novo Nordisk Pharmaceutical Industries, LP is $88,528, with a median of $88,528. Salaries range from $88,528 to $88,528.
The H-1B approval rate for Financial and Investment Analysts positions at Novo Nordisk Pharmaceutical Industries, LP is 100% based on 1 DOL filings.
See how Financial and Investment Analysts salaries compare across different H-1B sponsors.